Trade Name: FULVIDAX
Chemocare.com uses generic names in all descriptions of drugs. Faslodex
is the trade name for fulvestrant. In some cases, health care
professionals may use the trade name faslodex when referring to the
generic drug name fulvestrant.
Fulvestrant is a hormone therapy. It fights cancer as
an "estrogen receptor downregulator." (For more detail see "How
this drug works," below).
What this drug is used for:
- To treat estrogen receptor positive metastatic breast cancer
(cancer that has spread) in postmenopausal women, with disease
progression following antiestrogen therapy.
If a drug has been approved for one use, physicians may
elect to use this same drug for other problems if they believe it may be
How this drug is given:
- As an injection into the muscle (intramuscular, IM).
- Fulvestrant is usually given as a once a month injection. Your
doctor will determine any variations to this dosing or schedule.
Important things to remember about the side effects of fulvestrant :
The following side effects are common (occurring in greater than
30%) for patients taking fulvestrant:
- Most people do not experience all of the side effects listed.
- Side effects are often predictable in terms of their onset and
- Side effects are almost always reversible and will go away after
treatment is complete.
- There are many options to help minimize or prevent side effects.
- There is no relationship between the presence or severity of side
effects and the effectiveness of the medication.
These side effects are less common side effects (occurring in about
10-29%) of patients receiving fulvestrant:
- None occurring greater than 30%
- Nausea and vomiting
- Hot flashes (see sexuality)
- Sore throat (pharyngitis, see cold symptoms)
- Bone pain
- Abdominal pain
- Injection site reaction with mild temporary pain and swelling at